Biotech Century Therapeutics to offer 10.6 million shares in IPO, priced at $18 to $20 each

Biotech Century Therapeutics to offer 10.6 million shares in IPO, priced at $18 to $20 each
·1 min read

Biotech Century Therapeutics Inc. set terms for its initial public offering on Monday, with plans to offer 10.6 million shares priced at $18 to $20 each. The company has applied to list on Nasdaq, under the ticker symbol "IPSC." JP Morgan, BofA Securities, SVB Leerink and Piper Sandler are underwriting the deal. Proceeds will be used to fund pre-clinical activity and research and development, as well as working capital and general corporate purposes. "e are an innovative biotechnology company de

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting